Harborview Advisors’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | $372K | Buy |
6,286
+5
| +0.1% | +$296 | 0.21% | 77 |
|
|
2021
Q2 | $420K | Buy |
6,281
+5
| +0.1% | +$334 | 0.24% | 70 |
|
|
2021
Q1 | $396K | Buy |
6,276
+3
| +0% | +$189 | 0.24% | 69 |
|
|
2020
Q4 | $389K | Buy |
6,273
+3
| +0% | +$186 | 0.26% | 67 |
|
|
2020
Q3 | $378K | Buy |
6,270
+59
| +0.9% | +$3.56K | 0.29% | 63 |
|
|
2020
Q2 | $365K | Buy |
6,211
+3
| +0% | +$176 | 0.3% | 59 |
|
|
2020
Q1 | $346K | Buy |
6,208
+3
| +0% | +$167 | 0.34% | 55 |
|
|
2019
Q4 | $398K | Buy |
6,205
+400
| +7% | +$25.7K | 0.31% | 49 |
|
|
2019
Q3 | $294K | Sell |
5,805
-300
| -5% | -$15.2K | 0.24% | 62 |
|
|
2019
Q2 | $277K | Buy |
+6,105
| New | +$277K | 0.22% | 65 |
|